Understanding how semaglutide interacts with thyroid dysfunction is essential before starting any new medication
Timing, Frequency, and Severity Patterns in GLP-1-Related Diarrhea Diarrhea onset typically coincides with dose escalation phases
Eli Lilly, the maker of Zepbound and Mounjaro, had pushed back against the OFA's assertion that shortages of tirzepatide were still in place, and has also claimed that versions of the drug made by compounded pharmacies are often "untested, unapproved knockoffs," according to NBC News
A 52-week phase 2 trial on AMG133 in people with overweight and obesity is ongoing (NCT05669599)
But microdosing may prevent a person from getting enough of the recommended dose for the drug to be effective, and, in many cases, side effects of GLP-1 treatment are temporary
Because retatrutide activates three receptor types simultaneously, its gastrointestinal side effect profile can be more intense than single or dual agonists